This inventor holds 3 USPTO granted patents. Top assignees: Farmitalia Carlo Erba, Farmitalia Carlo Erba S.r.l.. Active years: 1986-1990.
Location History:
- Milan, IT (1986)
- Merano, IT (1988 - 1990)
Company Filing History:
Years Active: 1986-1990
Title: The Innovative Contributions of Mauro Gigli
Introduction
Mauro Gigli is a notable inventor based in Merano, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor agents. With a total of 3 patents, his work has had a considerable impact on cancer treatment.
Latest Patents
Mauro Gigli's latest patents include innovative compounds such as 6-amino anthracyclines, which are processes for their preparation and use as antitumor agents. These compounds are derived from the reduction of corresponding 6-nitro derivatives using stannous chloride in the presence of sodium acetate or with palladium on charcoal in the presence of cyclohexene. Another significant patent involves nitro anthracyclines, which also exhibit anti-tumor activity. These anthracycline glycosides have specific structural formulas that contribute to their effectiveness in cancer treatment.
Career Highlights
Throughout his career, Mauro Gigli has worked with prominent companies in the pharmaceutical industry, including Farmitalia Carlo Erba and Farmitalia Carlo Erba S.r.l. His experience in these organizations has allowed him to develop and refine his innovative ideas, leading to the successful patenting of his inventions.
Collaborations
Mauro Gigli has collaborated with notable colleagues such as Francesco Angelucci and Sergio Penco. These partnerships have fostered a creative environment that has contributed to the advancement of their shared goals in pharmaceutical innovation.
Conclusion
Mauro Gigli's contributions to the field of pharmaceuticals, particularly in the development of antitumor agents, highlight his innovative spirit and dedication to improving cancer treatment. His patents and collaborations reflect a commitment to advancing medical science and enhancing patient care.